Nucleotide triphosphates and their incorporation into oligonucleotides
申请人:——
公开号:US20030004122A1
公开(公告)日:2003-01-02
The present invention relates to novel nucleotide triphosphates, methods of synthesis and process of incorporating these nucleotide triphosphates into oligonucleotides, and isolation of novel nucleic acid catalysts (e.g., ribozymes or DNAzymes). Also, provided are the use of novel enzymatic nucleic acid molecules to inhibit HER2/neu/ErbB2 gene expression and their applications in human therapy.
本发明涉及新颖的核苷酸三磷酸盐,合成方法和将这些核苷酸三磷酸盐合成到寡核苷酸中的过程,以及新颖的核酸催化剂(例如核糖酶或DNA酶)的分离。此外,提供了使用新型酶促核酸分子抑制HER2 / neu / ErbB2基因表达的方法,并将其应用于人类治疗。
Ribozymes directed against flt-1
申请人:RIBOZYME PHARMACEUTICALS, INC.
公开号:EP1321521A1
公开(公告)日:2003-06-25
Nucleic acid catalysts which modulate the expression of flt-1 gene; methods of delivery, screening, identification, synthesis, deprotection, purification of nucleic acid catalysts and process for identification of nucleic acid molecules is described.
Nucleoside triphosphates and their incorporation into ribozymes
申请人:RIBOZYME PHARMACEUTICALS, INC.
公开号:EP1493818A2
公开(公告)日:2005-01-05
Novel nucleotide triphosphates, methods of synthesis and process of incorporating these nucleotide triphosphates into oligonucleotides, and isolation of novel nucleic acid catalysts (e.g. ribozymes) are disclosed.